BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35411943)

  • 21. miR-378a regulates keratinocyte responsiveness to interleukin-17A in psoriasis.
    Xia P; Pasquali L; Gao C; Srivastava A; Khera N; Freisenhausen JC; Luo L; Rosén E; van Lierop A; Homey B; Pivarcsi A; Sonkoly E
    Br J Dermatol; 2022 Aug; 187(2):211-222. PubMed ID: 35257359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
    Varshney P; Saini N
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.
    Furue K; Ito T; Tanaka Y; Hashimoto-Hachiya A; Takemura M; Murata M; Kido-Nakahara M; Tsuji G; Nakahara T; Furue M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.
    Peric M; Koglin S; Kim SM; Morizane S; Besch R; Prinz JC; Ruzicka T; Gallo RL; Schauber J
    J Immunol; 2008 Dec; 181(12):8504-12. PubMed ID: 19050268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
    Varshney P; Narasimhan A; Mittal S; Malik G; Sardana K; Saini N
    Sci Rep; 2016 Jan; 6():19295. PubMed ID: 26781963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
    J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
    Shi X; Jin L; Dang E; Chang T; Feng Z; Liu Y; Wang G
    J Invest Dermatol; 2011 Dec; 131(12):2401-8. PubMed ID: 21796151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.
    Tohyama M; Hanakawa Y; Shirakata Y; Dai X; Yang L; Hirakawa S; Tokumaru S; Okazaki H; Sayama K; Hashimoto K
    Eur J Immunol; 2009 Oct; 39(10):2779-88. PubMed ID: 19731362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different growth properties in response to epidermal growth factor and interleukin-6 of primary keratinocytes derived from normal and psoriatic lesional skin.
    Oyama N; Sekimata M; Nihei Y; Iwatsuki K; Homma Y; Kaneko F
    J Dermatol Sci; 1998 Jan; 16(2):120-8. PubMed ID: 9459124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IκBζ is a key driver in the development of psoriasis.
    Johansen C; Mose M; Ommen P; Bertelsen T; Vinter H; Hailfinger S; Lorscheid S; Schulze-Osthoff K; Iversen L
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):E5825-33. PubMed ID: 26460049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes.
    Tohyama M; Shirakata Y; Hanakawa Y; Dai X; Shiraishi K; Murakami M; Miyawaki S; Mori H; Utsunomiya R; Masuda K; Hashimoto K; Sayama K
    Eur J Immunol; 2018 Jan; 48(1):168-179. PubMed ID: 28901004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PFN1 Prevents Psoriasis Pathogenesis through IκBζ Regulation.
    Mok BR; Kim AR; Baek SH; Ahn JH; Seok SH; Shin JU; Kim DH
    J Invest Dermatol; 2022 Sep; 142(9):2455-2463.e9. PubMed ID: 35148999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytes.
    Simanski M; Rademacher F; Schröder L; Schumacher HM; Gläser R; Harder J
    PLoS One; 2013; 8(3):e59531. PubMed ID: 23555696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways.
    Tollenaere MAX; Hebsgaard J; Ewald DA; Lovato P; Garcet S; Li X; Pilger SD; Tiirikainen ML; Bertelsen M; Krueger JG; Norsgaard H
    Br J Dermatol; 2021 Sep; 185(3):585-594. PubMed ID: 33792895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
    Srikanth M; Rasool M
    Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis
    Liu XT; Shi ZR; Lu SY; Hong D; Qiu XN; Tan GZ; Xiong H; Guo Q; Wang L
    Front Immunol; 2022; 13():817040. PubMed ID: 35401573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
    Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K
    J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.